INTRODUCTION {#ss1}
============

Human rhinoviruses (HRVs), members of the *Picornaviridae* family \[[@b48]\], are recognized as the most frequent viral agents in humans presenting with symptoms of the common cold \[[@b7]\]. The profile of HRVs has been raised as a result of widening use of sensitive molecular methods of detection compared with in vitro cultivation \[[@b15]; [@b3]; [@b38]; [@b1]; [@b47]; [@b39]\], with an increase in the observations of association with lower respiratory tract infection \[[@b19]; [@b20], [@b21]; [@b16]; [@b25]; [@b23]; [@b36]\]. A number of other studies have suggested that respiratory illness, presenting with wheezing, rales and respiratory distress may be associated with HRVs \[[@b5]; [@b6]; [@b43]; [@b27], [@b28]\].

Sensitive RT-PCR and sequencing has been used to type rhinoviruses as HRV-A, HRV-B, and HRV-C, with HRV-C being discovered as recently as 2006 \[[@b20]; [@b24]\]. These PCR methods have also enabled studies on HRV disease burden in hospitalized infants and children under 5 years old \[[@b26]; [@b28], [@b27]\], including sub-Saharan Africa \[[@b30]; [@b33]; [@b46]\]. Molecular studies suggest almost equal prevalence of HRV-A and HRV-C with similar global distribution patterns \[reviewed in [@b42]\]. Although most of the epidemiological studies on HRV-C have focused on hospitalized or asthmatic children, the clinical outcomes of HRV-C infection, which was initially controversial, shows association with severe disease including asthma and acute wheezing \[[@b24]; [@b39]; [@b28]; [@b35]; [@b36]; [@b44]\].

HRVs are non-enveloped viruses with an icosahedral capsid enclosing a single-stranded, positive sense RNA genome that is translated in the cytoplasm \[[@b40]\]. The viral polyprotein is divided into P1, P2, and P3 regions, with the P1 region encoding the capsid proteins VP4, VP2, VP3, and VP1, while the P2 and P3 regions encode non-structural proteins 2APro, 2B, 2C, 3A, 3B (VPg), 2CPro and 3DPol \[reviewed by [@b18]\]. Sequencing of the VP1 led to the classification of HRVs into three species (HRV-A-C) \[[@b22]\] and recently, use of the VP4/VP2 junction, which is less variable and more easy to amplify than VP1, has replicated the earlier VP1 genetic classification \[[@b49]; [@b37]\].

There is little information on the molecular epidemiology of HRVs in sub-Saharan Africa \[[@b34]\]. A recent study associated clinical disease with HRV infection in 58.2% of hospitalized children, most of whom were under 2 years of age (72%), with species distribution of 37% HRV-A, 11% HRV-B, and 52% HRV-C \[[@b44]\] in South Africa. The lack of adequate information on the molecular epidemiology of HRV in tropical sub-Saharan Africa may be attributable to the presumed mild nature of the illness, scarcity of molecular laboratories, unreliably in vitro culture methods \[[@b12]; [@b14]\], and the impracticality of sero-diagnosis due to the large numbers (\>100) of identified serotypes \[[@b10]; [@b13]\].

In this study, the VP4/VP2 junction of HRV samples which were collected from children attending Kilifi District Hospital, coastal Kenya between the years 2007 and 2009 was sequenced. These samples were taken from children presenting with a range of respiratory illness severity, from very severe lower respiratory tract infection to those with and without upper respiratory tract illness. The information on HRV species distribution in rural coastal Kenya, the seasonal prevalence of such species as well as the sequence database of African HRV will increase the global knowledge base of these viruses.

MATERIALS AND METHODS {#ss2}
=====================

Patients and Samples {#ss2-1}
--------------------

The study was undertaken with samples from children presenting to the Kilifi District Hospital, which is located on the coast of Kenya approximately 60 km from Mombasa city. The District comprises a largely rural population of subsistence farmers and experiences an equatorial climate with rains predominantly falling in the months of April to July and November to December. Further details of the study area and respiratory virus disease surveillance through Kilifi District Hospital can be found in previous reports \[[@b32]; [@b4]\]. Nasopharyngeal wash or aspirate residues collected from 1912 children aged 1 day---12 years between January 2007 and December 2009, and stored in viral transport medium at -80°C, were tested for the presence of HRV. The children were outpatients (254) presenting either for routine immunization and categorized as without respiratory infection or with signs and symptoms of upper respiratory tract infection \[[@b4]\], or inpatients (1,759) with signs and symptoms consistent with lower respiratory tract infection and categorized as either mild, severe or very severe following WHO syndromic criteria \[[@b31]\]. Written informed consent was obtained from the parent/guardian. This study was approved by the Kenya National Ethical Review Committee and the University of Warwick Biomedical Research Ethics Sub-Committee.

RNA Extraction and PCR {#ss2-2}
----------------------

RNA was extracted from HRV positive samples using the Qiagen Viral RNA miniprep kit (Qiagen, West Sussex, UK) following the manufacturer,s instructions. Diagnostic PCR to confirm the presence of HRV genetic material was performed using a real-time RT-PCR with primers and probe targeting the 5, un-translated region \[[@b11]\]. For VP4/VP2 amplification, one tube RT-PCR was performed using Qiagen OneStep RT-PCR kit. Primers amplifying VP4/VP2 \[[@b49]\] were used at a concentration of 1 µM each per reaction in a total volume of 25 µl. PCR products were purified using Qiagen PCR purification Kit and sequenced with both the outer and inner primers in a BigDye chain terminator reaction and analyzed in a ABI 3130xl instrument.

Sequence Analysis and Phylogenetics {#ss2-3}
-----------------------------------

The raw sequences were edited using BioEdit software, translated in Lasergene (DNAStar) and phylogenetic analysis performed with MEGA 5.01 software \[[@b45]\]. The evolutionary history was inferred using Neighbor-Joining method \[[@b41]\] using 1,000 bootstrap replicates \[[@b9]\]. Evolutionary distances were computed using the Kimura 2-parameter \[[@b17]\]. HRV typing of the samples was determined by comparison with reference sequences from GenBank encoding VP4/VP2 protein. Intra-species patristic distances (p-distances) were tested by Neighbor-Joining method using 2,000 bootstrap replicates in MEGA 5.01 software, together with sequences downloaded from http://www.picornaviridae.com/news.htm (Tables SI and SII). Strains as used in this study refer to those reference sequences identified genetically without supporting serotypic information. Samples were considered to form a monophyletic grouping if they had a bootstrap value ≥ 90%. Statistical analyses were done in Stata version 11.0 (StataCorp LP, College Station, TX, www.stata.com) and graphs drawn in GraphPad Prism version 5.01 for Windows (GraphPad Software, San Diego, CA, www.graphpad.com"). Fisher,s exact test was used to test for independence of two categorical variables, while Spearmans correlation was used to test the associations between HRV and climatic conditions.

RESULTS {#ss3}
=======

Diagnostic real-time PCR identified 23% (441/1,912) of samples as HRV positive. Of these 86% (380/441) were from inpatient children with lower respiratory tract infection, while 14% (61/441) were from outpatient children. The median age (IQR) of non-acute respiratory infection, upper respiratory tract infection, mild lower respiratory tract infection, severe lower respiratory tract infection, and very severe lower respiratory tract infection children was 3.4 months (m) (3.2--11.8 m), 10.4 m (2.0--16.6 m), 18.8 m (9.5--26.9 m), 9.1 m (3.2--19.0 m), and 7.1 m (1.7--23.3 m) respectively. In general, the prevalence of HRV in inpatients was 22% (380/1,759) and 24% (61/254) in outpatients.

Distribution of HRV Species {#ss3-1}
---------------------------

The VP4/VP2 region of the genome was amplified from the 441 HRV positive samples with 75% (332/441) success. While 25% (109) samples in total were un-classified to species, the proportions differed significantly between outpatients and inpatients (44% (27/61) vs. 22% (82/380)), as shown in [Table I](#tbl1){ref-type="table"} (*P* \< 0.001). In the un-classified category, 90% (98/109) failed to amplify and 10% (11) had poor sequence readout. Of the 98 samples that failed to amplify, 65% (69) had late cycle threshold (Ct) values (above 30 cycles), within the real-time diagnostic assay. The distribution of HRV in 298 classified inpatient samples was 47% (141) HRV-A, 4.4% (13) HRV-B, and 48% (144) HRV-C; this distribution did not differ significantly by lower respiratory tract infection severity (*P* = 0.175). In the outpatients, of 34 classified viruses, the proportion of HRV-A was 41%, HRV-B 15%, HRV-C 44% and the distribution did not differ significantly between children with and without upper respiratory tract infection (*P* = 0.221).

###### 

HRV Species Distribution and Proportion Un-Classified From Pediatric (Under 12 Years of Age) Cases Identified at Kilifi District Hospital Outpatient Clinic and Inpatient Wards 2007--2009

  Category    HRV-A         HRV-B       HRV-C         Un-typed      Total
  ----------- ------------- ----------- ------------- ------------- -------
  Non-ARI     8 (34.78)     1 (4.35)    4 (17.39)     10 (43.48)    23
  URTI        6 (15.79)     4 (10.53)   11 (28.95)    17 (44.74)    38
  Mild        18 (43.9)     2 (4.88)    15 (36.59)    6 (14.63)     41
  Severe      96 (34.91)    7 (2.55)    111 (40.36)   61 (22.18)    275
  V. Severe   27 (42.19)    4 (6.25)    18 (28.12)    15 (23.44)    64
  Total       155 (35.15)   18 (4.08)   159 (36.05)   109 (24.72)   441

URTI, upper respiratory tract infection; ARI, acute respiratory illness; un-typed, unclassified.

Seasonal Distribution of the HRV Species {#ss3-2}
----------------------------------------

Cases of HRV were identified in Kilifi District Hospital throughout the year over the 3-year study period with higher proportions being seen in the months February 2007, June--July in 2007, August--September 2008, February 2009, April--June 2009, and November 2009, while lower proportions were observed between October--November 2007 and November--December 2008 ([Fig. 1](#fig01){ref-type="fig"}).

![The monthly distribution of HRV species over a 3-year period diagnosed in children admitted with lower respiratory tract infection to Kilifi District Hospital, 2007--2009. Also included on the right *y*-axis are the proportions of the samples from inpatients with lower respiratory tract infection that were HRV positive.](jmv0084-0823-f1){#fig01}

The distribution of the HRV species and the proportion of samples positive, in the inpatients, over the 3-year period is shown in [Figure 1](#fig01){ref-type="fig"}. HRV-A and C co-circulated in most months of surveillance, and while either was rarely absent (e.g., in the months of November 2008--January 2009), the numbers fluctuated considerably on an irregular basis. In contrast, HRV-B occurred only rarely and sporadically throughout the 3 years. Peak admissions of HRV-A and HRV-C cases did not obviously segregate or alternate and were not regularly seasonal. Numbers of HRV-C cases were higher in July 2007, and again in September 2008; while HRV-A cases were higher in July 2007, February and June 2008. There was no clear association between the monthly number of HRV cases and mean relative humidity (r^2^ = 0.1507, *P* = 0.380) or daily mean rainfall (r^2^ = -0.1399, *P* = 0.416) over the period of this study ([Fig. 2](#fig02){ref-type="fig"}).

![Average daily rainfall (mm, primary *y*-axis) and relative humidity (%, secondary *y*-axis), by month over the period 2007--2009, for Kilifi (source Kilifi Institute of Agriculture) and corresponding monthly HRV cases admitted to Kilifi District Hospital (primary *y*-axis). Note that monthly weather data represent averages for the 3 years.](jmv0084-0823-f2){#fig02}

Relatedness of Kilifi Sequences to Other HRV Sequences {#ss3-3}
------------------------------------------------------

The Kilifi sequences for each of the species formed numerous unique clusters with mean nucleotide identity of 76.4% (range 52.2%--97.6%) for HRV-A, 74.2% (range 44.5--99.7%) for HRV-B, and 68% (range 51.0--98.9%) for HRV-C, suggesting considerable diversity in strains/serotypes present in the population. In the cases of HRV-A and HRV-B most sequences clustered with known serotypes or strains from around the world ([Figs. 3](#fig03){ref-type="fig"} and [4](#fig04){ref-type="fig"}). In contrast, many of the sequences of HRV-C identified in circulation in Kilifi ([Fig. 5](#fig05){ref-type="fig"}) did not cluster with any published strains that also are based on sequencing of the VP4/VP2 junction. The Kilifi sequences (most easily seen for HRV-A and HRV-B) showed reasonable genetic deviation from nearest known strains/serotypes, generally with mean nucleotide differences of 25% (range 15.1--48.0%) for all the three HRV species.

![A phylogenetic analysis of HRV-A sequences from Kilifi and reference sequences from Genbank. Sequences with closed circles denote known serotypes, while those with open circles denote previously described strains. Bootstrap values are (2,000 replicates) shown on the branches, with values \<90% omitted from the tree. The tree was drawn to scale, with branch lengths in the same units (p-distance) used to infer the phylogenetic tree. Kilifi sequences are designated K-number (KI for inpatient sequences and KO for outpatient sequences).](jmv0084-0823-f3){#fig03}

![A phylogenetic analysis of HRV-B sequences from Kilifi alongside reference serotypes and strains from Genbank. Sequences with closed circles denote known serotypes, while those with open circles denote previously described strains. The percentage of replicate trees in which the associated taxa clustered together in the bootstrap test (2,000 replicates) is shown next to the branches. Bootstrap values \<90% have been omitted from the tree. The tree is drawn to scale, with branch lengths in the same units (p-distance) used to infer the phylogenetic tree. Kilifi sequences are designated K-number (KI for inpatient sequences and KO for outpatient sequences).](jmv0084-0823-f4){#fig04}

![A phylogenetic analysis of HRV-C sequences from Kilifi alongside reference serotypes and strains from Genbank. Sequences with closed circles denote known strains. The percentage of replicate trees in which the associated taxa clustered together in the bootstrap test (2,000 replicates) is shown next to the branches. Bootstrap values \<90% have been omitted from the tree. The tree is drawn to scale, with branch lengths in the same units (p-distance) used to infer the phylogenetic tree. Kilifi sequences are designated K-number (KI for inpatient sequences and KO for outpatient sequences).](jmv0084-0823-f5){#fig05}

One sequence (KI-5607), that seemed an offshoot in HRV-B ([Fig. 4](#fig04){ref-type="fig"}) was found to be human enterovirus 68 when compared with other sequences from the GenBank. The KI-5607 had 95% nucleotide identity to strain JPOC10-396 isolated in Osaka Japan with GenBank accession number AB601884.

DISCUSSION {#ss4}
==========

The distribution of HRV species in sub-Saharan Africa is not well described although there are some reports on the overall prevalence of HRV. Recently, epidemiological studies in sub-Saharan Africa showed the prevalence of HRV in children \<5 years presenting to a primary care center with acute respiratory infection as 17% in rural Senegal \[Niang et al., [@b30]\], 41% in rural Mozambique \[[@b33]\], and 33% in Pretoria South Africa \[[@b46]\]. The equivalent prevalence in inpatients from the present study was 22%. The current study reports the species typing of 441 Kilifi HRV positive samples by the genetic analysis of the VP4/VP2 junction. Failure to type 25% of HRV positive samples was largely attributed to PCR failure (65%) due to low viral load (inferred from Ct value) than the severity category. However, it cannot be excluded that certain genetic variants were missed in the typing assay due to their variability in the primer-annealing sites, leading to PCR failure.

All the three species of HRV were found to be circulating in children under 12 years of age in Kilifi, with occurrence of 47% HRV-A, 5% HRV-B, and 48% HRV-C. Such patterns of species distribution have been reported elsewhere in the USA \[[@b29]\] and Cape Town, South Africa \[[@b44]\].

The current study also identified a human enterovirus 68, which was diagnosed initially as HRV by real-time PCR assay. This discrepancy in diagnosis was resolved after BLAST search correctly identified the virus. This was also supported by its unique topology on the HRV-B phylogenetic tree ([Fig. 4](#fig04){ref-type="fig"}). The identification of non-HRV is not unique as the PCR primers used the Kilifi HRV diagnostic platform are capable of amplifying other non-HRV human enteroviruses \[[@b49]\].

There was neither a clear seasonal circulation pattern nor an identifiable influence of weather (rainfall and humidity) on HRV occurrence in Kilifi. This is in contrast to a study from Germany, which showed an association between relative humidity and rhinovirus infection in a hospitalized cohort \[[@b8]\].

This study also noted lack of an association between inpatient severity and any of the HRV species. Other studies elsewhere have shown evidence of the involvement of HRV-C in infants and toddlers with wheeze, and asthma in older children \[[@b20]; [@b16]; [@b28]\] and a shorter duration of asthma symptoms and less cough in HRV-A infected children \[[@b2]\]. The discrepancy in associating HRV-C with disease severity in the current study may be as a result of either the broad case definition used hence masking the broad definitions of non-acute respiratory infection and lower respiratory tract infection or as a result of the emergence of HRV-C strains with altered disease causing potential.

This study did not attempt to compare inpatient and outpatient cases to identify HRV disease severity by species due to the bias in design. It is therefore important that studies in African settings focus on case--control studies as well as collecting adequate clinical history to help decipher the clinical relevance of HRVs.

There was high diversity of sequences in circulation in all the Kilifi HRV species, although sequences of HRV-A and HRV-B clustered with known serotypes and strains. However there were a large number of clusters for HRV-C that had no closely associated strain from the literature. The formation of few clusters between the known HRV-C and Kilifi sequences compared with HRV-A and HRV-B was mostly like due to the availability of few HRV-C VP4/VP2 sequences in the GenBank.
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